- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $45.86M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $22.24M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.03M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.08M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $47.16M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $61.35M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $47.46M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $61.56M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $36.12M |
| Capex | Q1 2025 · Mar 31, 2024 | $6K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$6.67M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $28.69M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $35.31M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$4.03 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$4.03 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.45M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$7.42M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$7.8M |